Natural Born Killers: NK Cells in Cancer Therapy
Cellular therapy has emerged as an attractive option for the treatment of cancer, and adoptive transfer of chimeric antigen receptor (CAR) expressing T cells has gained FDA approval in hematologic malignancy. However, limited efficacy was observed using CAR-T therapy in solid tumors. Natural killer...
Main Authors: | S. Elizabeth Franks, Benjamin Wolfson, James W. Hodge |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/8/2131 |
Similar Items
-
The application of natural killer (NK) cell immunotherapy for the treatment of cancer
by: Rayne H Rouce, et al.
Published: (2015-11-01) -
Inhibition of WEE1 kinase and cell cycle checkpoint activation sensitizes head and neck cancers to natural killer cell therapies
by: Jay Friedman, et al.
Published: (2018-06-01) -
Immunotherapy with NK cells: recent developments in gene modification open up new avenues
by: Lisa Marie Reindl, et al.
Published: (2020-01-01) -
New Orders to an Old Soldier: Optimizing NK Cells for Adoptive Immunotherapy in Hematology
by: Mehmet Gunduz, et al.
Published: (2021-09-01) -
Natural Killer Cells: The Linchpin for Successful Cancer Immunotherapy
by: Kari A. Shaver, et al.
Published: (2021-04-01)